第一医药(600833) - 2015 Q3 - 季度财报

Financial Performance - Operating income for the first nine months rose by 7.16% to CNY 1,139,872,621.39 compared to the same period last year[6] - Net profit attributable to shareholders increased by 11.51% to CNY 32,473,784.70 compared to the same period last year[6] - Basic earnings per share rose by 11.57% to CNY 0.1456 compared to the same period last year[6] - Total operating revenue for Q3 2015 reached ¥356,383,032.77, an increase of 4.66% compared to ¥341,787,825.34 in Q3 2014[18] - Year-to-date operating revenue for 2015 was ¥1,139,872,621.39, up 7.15% from ¥1,063,759,068.03 in the same period last year[18] - Net profit for Q3 2015 was ¥9,280,197.74, a decrease of 4.66% from ¥9,734,609.15 in Q3 2014[18] - Year-to-date net profit reached ¥32,473,784.70, up 11.93% from ¥29,121,952.94 in the same period last year[18] - Basic earnings per share for Q3 2015 were ¥0.0416, down from ¥0.0436 in Q3 2014[18] Assets and Liabilities - Total assets increased by 9.01% to CNY 1,178,360,345.42 compared to the end of the previous year[6] - Current assets totaled RMB 596,418,203.96, slightly up from RMB 585,995,376.38 at the start of the year, indicating a growth of about 0.7%[12] - Non-current assets totaled RMB 581,942,141.46, up from RMB 494,984,509.16, indicating a growth of about 17.5%[12] - Total liabilities were reported at RMB 436,741,399.98, a slight increase from RMB 430,009,165.62, reflecting a growth of about 1.7%[13] - The current liabilities decreased to RMB 324,279,027.74 from RMB 340,372,104.88, a reduction of approximately 4.7%[13] Shareholder Information - The number of shareholders reached 26,874 by the end of the reporting period[8] - The largest shareholder, Shanghai Xindada Commercial (Group) Co., Ltd., holds 23.39% of the shares[8] Cash Flow - Cash flow from operating activities increased by 22.01% to CNY 55,586,235.16 compared to the same period last year[6] - The total cash inflow from operating activities for the first nine months of 2015 was CNY 1,208,347,683.58, an increase of 5.93% compared to CNY 1,140,710,243.60 in the same period last year[21] - The net cash flow from operating activities was CNY 55,586,235.16, up from CNY 45,559,035.15, representing a year-over-year increase of 22.5%[21] - The cash inflow from investment activities totaled CNY 3,958,038.09, compared to CNY 3,609,746.71 in the previous year, marking an increase of 9.65%[21] - The net cash flow from investment activities was CNY 1,805,925.38, significantly higher than CNY 1,148,734.12 from the previous year, indicating a growth of 57.4%[21] - The total cash inflow from operating activities for the parent company was CNY 577,037,361.54, an increase of 9.5% from CNY 527,065,904.03 in the previous year[22] - The net cash flow from operating activities for the parent company was CNY 55,194,816.83, up from CNY 34,223,386.48, indicating a year-over-year increase of 61.3%[22] Other Financial Metrics - Significant increase in prepayments by 189.39% to CNY 8,402,283.69 compared to the beginning of the year[9] - Deferred income tax liabilities increased by 30.69% to CNY 98,412,239.98 due to rising stock prices[9] - The company's cash and cash equivalents increased to RMB 209,642,991.64 from RMB 163,323,845.50, representing a growth of approximately 28.4%[12] - Accounts receivable rose to RMB 160,885,147.79 from RMB 131,415,698.66, marking an increase of about 22.4%[12] - Inventory decreased significantly to RMB 212,435,873.65 from RMB 273,525,913.70, a decline of approximately 22.3%[12] - The company's equity attributable to shareholders increased to RMB 734,611,629.55 from RMB 643,963,404.03, showing a growth of approximately 14.1%[13] - The company reported a significant increase in employee compensation payable, rising to RMB 14,351,353.48 from RMB 2,038,859.04, an increase of approximately 605.5%[13] - Other comprehensive income after tax for Q3 2015 was -¥61,141,480.12, compared to ¥50,542,341.95 in Q3 2014[18] - Total comprehensive income for Q3 2015 was -¥51,861,282.38, a significant decrease from ¥60,276,951.10 in Q3 2014[18] - The company reported an investment income of ¥44,205.15 for Q3 2015, slightly up from ¥40,695.15 in Q3 2014[18]